{"log_id": 9161073956052133771, "direction": 0, "words_result_num": 31, "words_result": [{"probability": {"variance": 0.000114, "average": 0.989297, "min": 0.978614}, "location": {"width": 48, "top": 92, "height": 27, "left": 1115}, "words": "药品"}, {"probability": {"variance": 0.061246, "average": 0.641751, "min": 0.413866}, "location": {"width": 72, "top": 131, "height": 26, "left": 1101}, "words": "批准"}, {"probability": {"variance": 6.5e-05, "average": 0.982173, "min": 0.974115}, "location": {"width": 67, "top": 168, "height": 28, "left": 1099}, "words": "件骑"}, {"probability": {"variance": 3.8e-05, "average": 0.997077, "min": 0.976729}, "location": {"width": 231, "top": 216, "height": 27, "left": 231}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 0.001354, "average": 0.991252, "min": 0.76887}, "location": {"width": 760, "top": 252, "height": 39, "left": 247}, "words": "动物试验显示高于本品为临床每日最大剂量时家兔和大鼠会出现胚胎毒性和致畸性以及"}, {"probability": {"variance": 0.002101, "average": 0.987233, "min": 0.733534}, "location": {"width": 661, "top": 300, "height": 36, "left": 226}, "words": "母体毒性(见【药理毒理】)。本品未在人体进行相应研究,因此孕妇慎用"}, {"probability": {"variance": 0.001915, "average": 0.99039, "min": 0.72238}, "location": {"width": 777, "top": 345, "height": 36, "left": 227}, "words": "目前尚未知道眼睛局部用皮质类固醇是否会导致充分的全身吸收以至在母乳中产生的可检"}, {"probability": {"variance": 2.7e-05, "average": 0.997381, "min": 0.970506}, "location": {"width": 785, "top": 389, "height": 37, "left": 226}, "words": "测的量。全身用药的类固醇可以出现在母乳中,并能抑制生长,影响内源性皮质类固醇的产"}, {"probability": {"variance": 4.5e-05, "average": 0.996842, "min": 0.966798}, "location": {"width": 480, "top": 439, "height": 31, "left": 227}, "words": "生或者产生其它不利的影响。因此哺乳期女性慎用本品"}, {"probability": {"variance": 7e-06, "average": 0.998375, "min": 0.99255}, "location": {"width": 110, "top": 562, "height": 26, "left": 235}, "words": "【儿童用药】"}, {"probability": {"variance": 0.000102, "average": 0.995916, "min": 0.949644}, "location": {"width": 461, "top": 601, "height": 33, "left": 251}, "words": "目前尚无用于儿童用药的安全性和有效性的足够资料"}, {"probability": {"variance": 1e-06, "average": 0.998463, "min": 0.996203}, "location": {"width": 111, "top": 679, "height": 24, "left": 234}, "words": "【老年用药】"}, {"probability": {"variance": 0.001706, "average": 0.99154, "min": 0.744873}, "location": {"width": 743, "top": 715, "height": 35, "left": 249}, "words": "目前尚无老年患者使用本品需要特别注意的事项,在权衡利弊的前提下,遵医嘱使用"}, {"probability": {"variance": 7e-06, "average": 0.997671, "min": 0.992154}, "location": {"width": 146, "top": 795, "height": 24, "left": 236}, "words": "【药物相互作用】"}, {"probability": {"variance": 0.002001, "average": 0.985431, "min": 0.813126}, "location": {"width": 321, "top": 837, "height": 27, "left": 252}, "words": "目前尚无有关药物的相互作用的资料"}, {"probability": {"variance": 3e-06, "average": 0.997958, "min": 0.994781}, "location": {"width": 111, "top": 913, "height": 24, "left": 236}, "words": "【药物过量】"}, {"probability": {"variance": 0.001158, "average": 0.984113, "min": 0.874218}, "location": {"width": 388, "top": 943, "height": 40, "left": 251}, "words": "目前尚无有关药物过量研究的足够资料。"}, {"probability": {"variance": 0.000386, "average": 0.989346, "min": 0.945647}, "location": {"width": 113, "top": 1027, "height": 25, "left": 236}, "words": "【临床试验】"}, {"probability": {"variance": 6.5e-05, "average": 0.996188, "min": 0.961339}, "location": {"width": 757, "top": 1068, "height": 30, "left": 254}, "words": "采用多中心、随机、单盲、阳性药物平行对照研究,确定本品对控制白内障摘除和人工"}, {"probability": {"variance": 0.003543, "average": 0.984075, "min": 0.6636}, "location": {"width": 782, "top": 1112, "height": 30, "left": 229}, "words": "晶状体植入术后炎症反应和过敏性结膜炎的有效性和安全性。研究对象为无并发症的白内障"}, {"probability": {"variance": 0.000354, "average": 0.992194, "min": 0.912996}, "location": {"width": 785, "top": 1157, "height": 30, "left": 229}, "words": "囊外或超声乳化摘除和后房型人工晶状体植入术后患者,临床明确诊断的过敏性结膜炎和春"}, {"probability": {"variance": 0.001129, "average": 0.987758, "min": 0.812945}, "location": {"width": 779, "top": 1201, "height": 31, "left": 231}, "words": "季卡他性结膜炎患者。每次1滴,滴入结膜囊,每日4次,用药14天。结果显示本品对白内降"}, {"probability": {"variance": 2.8e-05, "average": 0.997484, "min": 0.966894}, "location": {"width": 774, "top": 1246, "height": 30, "left": 230}, "words": "摘除及人工晶状体植入术后视物模糊、畏光、异物感、流泪、眼痛等症状,和睫状体充血"}, {"probability": {"variance": 0.00031, "average": 0.991826, "min": 0.890137}, "location": {"width": 775, "top": 1290, "height": 31, "left": 231}, "words": "角膜水肿、角膜后沉着物、前房浮游体、房水闪光、虹膜后黏连等体征的控制总疗效为88.2%"}, {"probability": {"variance": 0.001535, "average": 0.98613, "min": 0.7683}, "location": {"width": 777, "top": 1334, "height": 32, "left": 232}, "words": "与1%泼尼松龙滴眼液的85.9%相似,无显著性统计学差异,不良反应的发生率为2.7%;本品"}, {"probability": {"variance": 8.5e-05, "average": 0.996711, "min": 0.954412}, "location": {"width": 784, "top": 1381, "height": 27, "left": 231}, "words": "对过敏性结膜炎包括眼痒、流泪、异物感、不适感等症状,和分泌物、球结膜充血、眼睑和"}, {"probability": {"variance": 0.003274, "average": 0.985643, "min": 0.626625}, "location": {"width": 789, "top": 1426, "height": 27, "left": 229}, "words": "眼周组织的充血水肿等体征的控制总疗效为94.4%,与1%泼尼松龙滴眼液的94.6%相似无显"}, {"probability": {"variance": 0.023493, "average": 0.922419, "min": 0.429261}, "location": {"width": 854, "top": 1467, "height": 39, "left": 230}, "words": "著性统计学差异,不良反应发生率为1.3%临床试验结果表明氯替泼诺混悬滴眼液C0.医药"}, {"probability": {"variance": 8.7e-05, "average": 0.995889, "min": 0.952741}, "location": {"width": 719, "top": 1515, "height": 29, "left": 230}, "words": "对控制白内障摘除及人工晶状体植入术后炎症反应和过敏性结膜炎是安全、有效的"}, {"probability": {"variance": 0.024497, "average": 0.834867, "min": 0.669228}, "location": {"width": 144, "top": 1493, "height": 52, "left": 939}, "words": "有限公司"}, {"probability": {"variance": 0.004166, "average": 0.958588, "min": 0.846796}, "location": {"width": 104, "top": 1605, "height": 37, "left": 1073}, "words": "仅供存档"}], "language": 3}